Buchu Agathosma betulina (P.J.Bergius) Pillans
Also called: Barosma betulina (P.J.Bergius) Bartl. & H.L.Wendl. (synonym)
Buchu is an aromatic South African shrub; the name covers two traded species, Agathosma betulina and A. crenulata. Its dried leaves are used in teas and tonics and its essential oil as a blackcurrant-like flavoring. Human research is minimal.
- Category
- Botanical
- Part used
- Dried leaves; leaf essential oil
- Strongest evidence
- C Limited
- Native range
- Native to the south-western Cape Provinces of South Africa (POWO: "SW. Cape Prov.")
- Reviewed
- 2026-10-29
Class 3 Limited studies in people. A 2022 review (Front Pharmacol) says urgently needed clinical trials have not been conducted; the only human study it cites is one double-blind, placebo-controlled study in 30 men of a topical A. betulina oil gel. No oral trial was found. [2]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CMuscles and exercise1 topic
DHeart and blood vessels1 topic
DKidneys and bladder1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Urinary tract and other traditional uses | D | A 2022 review says urgently needed clinical trials have not been conducted. Laboratory tests showed moderate antimicrobial activity for a leaf extract but not the essential oil. [2] |
| Muscle pain and swelling after exercise (topical gel) | C | A 2022 review cites one double-blind, placebo-controlled study in 30 men (a 2002 research-unit report) in which an A. betulina oil gel applied three times daily reduced swelling and pain from exercise-induced muscle damage. [2] |
| Blood glucose, weight and blood pressure in rats | D | Aqueous buchu extract normalized glucose in diabetic rats, and in rats on a high-fat diet it reduced weight gain and returned diet-raised blood pressure to control values; the review authors say these results remain questionable in humans without trials. [2] |
Main constituents: More than 120 compounds, including volatile oils such as pulegone (a suspected liver toxin), at higher levels in A. crenulata than in A. betulina [1]; Diosphenol (unique to the genus; blackcurrant flavor), menthone, isomenthone and 8-mercapto-p-menthan-3-one in the essential oil [2]
Safety and side effects
- Liver (NIH LiverTox)Score DABCDEA: well known causeE: unlikely cause
LiverTox likelihood score D (possible, rare cause of clinically apparent liver injury), chapter updated March 3, 2023: a single case of acute …
Details and sources - Pregnancy and breastfeedingNothing found
No published information found in the sources checked.
Details and sources - Interactions with medicinesNothing found
No published information found in the sources checked.
Details and sources - Cancer evaluations (IARC, NTP)2 found
Each names the exact material tested, which may differ from a supplement.
Details and sources - FDA new dietary ingredient notificationsNone on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- LiverTox likelihood score D (possible, rare cause of clinically apparent liver injury): one published case of acute hepatitis in a person taking both buchu and rooibos tea; stopping buchu promptly is advised if liver injury appears. [1]
- Pulegone causes liver injury in rodents and depletes glutathione at large doses; A. crenulata contains more pulegone than A. betulina. [1]
- A 2022 review notes that pulegone is not water soluble, so its caution about pulegone does not apply to water extracts. [2]
- Generally well tolerated; minor side effects may include gastrointestinal upset and urinary tract irritation. [1]
Identity, quality and standardization
- Cultivating both species outside their natural habitat has produced hybrid plants, and buchu products are reported to be often adulterated. [2]
- Essential oil chemistry varies: diosphenol and isomenthone chemotypes of A. betulina are described, and pulegone has been used as a key identification marker. [2]
Regulatory status
- Germany: Kommission E issued a negative monograph (1990) stating that, since effectiveness had not been documented, buchu leaf could not be recommended; use as a flavor corrigent in teas was acceptable. [2]
- US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; manufacturers and distributors have initial responsibility for their safety. [3]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- No NDI notification naming buchu (Agathosma betulina) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-29). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P2]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC or NTP carcinogenicity evaluation of buchu was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). Separately, IARC classifies pulegone, a constituent of buchu oil, in Group 2B (Volume 108, 2016); this evaluation is of the pure compound, not of buchu. [P3]
- NTP technical reports list checked 2026-10-29: no report on buchu (NTP TR-563 covers the pure compound pulegone). [P4]
Liver (NIH LiverTox)
- LiverTox likelihood score D (possible, rare cause of clinically apparent liver injury), chapter updated March 3, 2023: a single case of acute hepatitis in a patient taking both buchu and rooibos tea; little evidence that buchu in low oral doses or as tea causes liver injury. [P5]
Interactions with medicines
- No published information found in the sources checked.
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- A 2022 review states that buchu supplements are often adulterated (citing Raman et al., 2015) and that cultivation of A. betulina and A. crenulata outside their natural habitat has produced hybrid plants. [P1]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity: at least one appropriate test or examination of each dietary-ingredient component (21 CFR 111.75(a)(1)(i)) — Required by the US dietary supplement cGMP rule for any component that is a dietary ingredient, unless FDA grants an exemption petition under 111.75(a)(1)(ii). [P6]
- Essential-oil profile (diosphenol, isomenthone, pulegone) to confirm species and chemotype — Two species are traded as buchu, hybrids occur in cultivation, and chemotypes differ in diosphenol and isomenthone; pulegone has served as a key identification marker. [P1]
- Pulegone content — LiverTox names pulegone a suspected hepatotoxin, present at higher levels in A. crenulata than A. betulina. [P5]
Supply and conservation
- Rising demand for buchu oil from 1990, with cultivation proving difficult, led to unsustainable harvesting; in 1999 South Africa's Agricultural Research Council began a project to cultivate buchu commercially so that it would not become extinct. [P1]
Absorption in people
- No published information found in the sources checked.
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- No published information found in the sources checked.
Sources for this profile
- Brendler T, Abdel-Tawab M. Buchu (Agathosma betulina and A. crenulata): Rightfully Forgotten or Underutilized? Front Pharmacol 2022;13:813142 (PMID 35197854; full text via Europe PMC, PMC8859318), 2022-02-07. ebi.ac.uk
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications, Agents classified by the IARC Monographs, Volumes 1–142 (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- NIH LiverTox (NIDDK). Buchu (Last Update: March 3, 2023), 2023-03-03. ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75 (Title 21 up to date as of 10/27/2026), 2026-10-27. ecfr.gov
Sources
- NIH LiverTox (NIDDK). Buchu (Last Update: March 3, 2023), 2023-03-03. ncbi.nlm.nih.gov
- Brendler T, Abdel-Tawab M. Buchu (Agathosma betulina and A. crenulata): Rightfully Forgotten or Underutilized? Front Pharmacol 2022;13:813142 (PMID 35197854; full text via Europe PMC, PMC8859318), 2022-02-07. ebi.ac.uk
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew; WCVP data (Govaerts et al., Sci Data 2021). Agathosma betulina (P.J.Bergius) Pillans (accessed 2026-10-29); synonyms from WCVP, 2026-10-29. powo.science.kew.org
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.